The series from the Russo brothers stars Priyanka Chopra Jonas and Richard Madden and debuts April 28.
the expensive and troubled drama from the Russo brothers that has been in the works since 2018, is getting a second chapter.that the series starring Priyanka Chopra Jonas and Richard Madden has been renewed for a second season ahead of its April 28 debut. It’s unclear how many episodes season two will consist of; the freshman run will consist of a mere six episodes. The news comes after the series debuted this month at South by Southwest.
Amazon and reps for the Russos’ AGBO declined to comment as sources say deals have not yet been finalized.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Priyanka Chopra Says She Reached Pay Equity for the First Time With 'Citadel'“I’m laughing about this, but it’s kind of nuts.”
Lire la suite »
Western Alliance stock soars nearly 40%, as Citadel boosts stake to over 5%Shares of Western Alliance Bancorp. shot up 38.8% in morning trading Tuesday, to stage a big bounce following the drubbing they suffered the past three...
Lire la suite »
Citadel discloses 5% stake in Western Alliance amid sell-offHedge fund Citadel on Tuesday said it bought a 5.3% stake in Western Alliance Bancorporation , sending a strong signal of confidence as the company was swept up in growing fears of a broader financial crisis after two other banks were seized.
Lire la suite »
Citadel, other funds seek bargains in smaller banks after sell-offHedge funds including Citadel have bought shares in smaller banks after a sell-off sparked by the failure of Silicon Valley Bank and Signature Bank, sending a signal of confidence as customers rushed to withdraw funds and investors feared a broader financial crisis.
Lire la suite »
Breakingviews - Pfizer’s $43 bln deal is a pricey pipeline fixPfizer has found a partial, costly replacement for waning sales of Covid-19 vaccines. The $225 billion pharmaceutical giant said Monday it had agreed to shell out $43 billion for oncology specialist Seagen , inclusive of net debt. Snag is, Pfizer’s return will probably be low, and the deal may not even receive antitrust approval.
Lire la suite »
Eargo’s New Hearing Aids Have Evolved—but They’re Still PriceyThe Eargo 7s perform reliably. But their price makes it hard to compete with more affordable over-the-counter hearing aids.
Lire la suite »